Unnamed: 0,title,date,stock,sentiment
753174.0,Lannett Says Anticipates Biosimilar Application for Insulin Glargine to Be Submitted by End of Calendar Year 2022,2020-06-11 06:53:00-04:00,LCI,neutral
753175.0,84 Biggest Movers From Yesterday,2020-05-08 05:34:00-04:00,LCI,neutral
753176.0,68 Stocks Moving In Thursday's Mid-Day Session,2020-05-07 12:42:00-04:00,LCI,neutral
753177.0,Mid-Day Market Update: Crude Oil Rises 8%; Vista Outdoor Shares Plunge,2020-05-07 12:00:00-04:00,LCI,negative
753178.0,"Lannett Narrows FY20 Net Sales Guidance From $530M-$550M to $535M-$545M, Cuts Adj. EBITDA Guidance From $145M-$160M To $137M-$147M",2020-05-06 16:46:00-04:00,LCI,negative
753179.0,"Lannett Q3 Adj. EPS $0.270 Misses $0.290 Estimate, Sales $144.372M Beat $134.520M Estimate",2020-05-06 16:45:00-04:00,LCI,negative
753180.0,"Lannett Shares Make Very Near Term Parabolic Move, Spike To Session High, Then Sell Off; Shares Currently Up ~1% Over Last Few Mins. Since Circulation Of FDA.gov Link Showing Letter From HEC Pharma USA",2020-04-22 12:29:00-04:00,LCI,positive
753181.0,Lannett Shares Spike To Session High On Volume As Traders Circulate Apr. 2020-Dated 'Prescribing Information' Letter From HEC Pharm USA CEO Disclosing Coordination With Lannett To Increase Availaiblity Of Azithromycin Tablet Product In US,2020-04-22 12:28:00-04:00,LCI,positive
753182.0,Lannett To Meet With FDA Regarding The Clinical Advancement Of Biosimilar Insulin Glargine On June 9,2020-04-08 06:53:00-04:00,LCI,neutral
753183.0,Lannett Begins Marketing Generic Adderall XR,2020-03-31 06:55:00-04:00,LCI,neutral
753184.0,Lannett Co shares are trading lower despite the company reporting better-than-expected Q2 sales results.,2020-02-06 10:26:00-05:00,LCI,neutral
753185.0,Lannett Raises FY20 Adj. Sales Guidance From $525M-$545M To $530M-$550M,2020-02-05 16:19:00-05:00,LCI,neutral
753186.0,"Lannett Q2 EPS $0.27, Inline, Sales $136.11M Beat $128.6M Estimate",2020-02-05 16:19:00-05:00,LCI,neutral
753187.0,Shares of several healthcare and biotech companies are trading higher as unconfirmed reports of progress towards a coronavirus treatment raise investor sentiment amid the virus outbreak. NOTE: The WHO played down these reports and said there are no known treatments.,2020-02-05 09:47:00-05:00,LCI,positive
753188.0,30 Stocks Moving in Monday's Pre-Market Session,2020-02-03 07:30:00-05:00,LCI,neutral
753189.0,"Shares of several companies in the healthcare and pharmaceutical space are trading lower, not currently seeing sector-specific news. NOTE: The global spread of the Wuhan coronavirus has caused equities across to sell off.",2020-01-24 11:40:00-05:00,LCI,neutral
753190.0,5 Drug Manufacturersâ€”Specialty & Generic Stocks Moving In Tuesday's After-Market Session,2020-01-21 23:34:00-05:00,LCI,neutral
753191.0,29 Healthcare Stocks Moving In Tuesday's After-Market Session,2020-01-21 23:28:00-05:00,LCI,neutral
753192.0,"Lannett shares are trading higher on continued momentum after the company announced it has received FDA approval of its NDA for Cocaine Hydrochloride Nasal Solution 4%, the company's branded local anesthetic product.",2020-01-14 14:15:00-05:00,LCI,positive
753193.0,Lannett Shares Jolted By FDA Approval Of Cocaine Spray For Nasal Surgery,2020-01-14 12:04:00-05:00,LCI,positive
753194.0,"Lannett shares are trading higher after the company announced it has received FDA approval of NDA for Cocaine Hydrochloride Nasal Solution 4%, the company's branded local anesthetic product.",2020-01-13 07:51:00-05:00,LCI,positive
753195.0,"Lannett Announces FDA Approval Of NDA For Branded Anesthetic Product, Cocaine Hydrochloride Nasal Solution 4%",2020-01-13 06:59:00-05:00,LCI,positive
753196.0,"Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules",2019-12-23 06:52:00-05:00,LCI,positive
753197.0,"Lannett Issues Voluntary Nationwide Recall Of Levetiracetam Oral Solution, 100mg/Ml Due To Microbial Contamination",2019-12-20 08:41:00-05:00,LCI,positive
753198.0,Lannett Reports Commencement Marketing Generic Adderall XR,2019-12-12 06:57:00-05:00,LCI,neutral
753199.0,"Benzinga Pro's Top 5 Stocks To Watch For Wed., Dec. 4, 2019: CRM, WDAY, GPRO, LCI, SPY",2019-12-04 08:41:00-05:00,LCI,positive
753200.0,12 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-12-04 07:34:00-05:00,LCI,neutral
753201.0,Lannett Announces Human Clinical Trial Of Biosimilar Insulin Glargine Met All Primary Endpoints,2019-12-04 06:53:00-05:00,LCI,neutral
753202.0,Lannett Enters Collaboration And License Agreement With North & South Brother Pharmacy Investment Co,2019-11-26 16:12:00-05:00,LCI,positive
753203.0,FDA Says Alerting Patients & Health Care Professionals To 2 Voluntary Recalls Of Ranitidine,2019-11-12 15:59:00-05:00,LCI,positive
753204.0,"Lannett shares are trading lower, continuing to slip following Q1 earnings.",2019-11-08 11:24:00-05:00,LCI,neutral
753205.0,94 Biggest Movers From Yesterday,2019-11-08 06:01:00-05:00,LCI,neutral
753206.0,75 Stocks Moving In Thursday's Mid-Day Session,2019-11-07 12:19:00-05:00,LCI,neutral
753207.0,Lannett Co shares are trading lower after the company reported Q1 EPS and sales results down fom last year.,2019-11-07 10:43:00-05:00,LCI,neutral
753208.0,Lannett Company Sees FY20 Sales $525M-$545M vs $535.75M Est.,2019-11-06 16:19:00-05:00,LCI,neutral
753209.0,"Lannett Co Inc Q1 EPS $0.22 Beats $0.19 Estimate, Sales $127.34M Beat $120.78M Estimate",2019-11-06 16:18:00-05:00,LCI,neutral
753210.0,Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS,2019-10-01 06:53:00-04:00,LCI,positive
753211.0,55 Biggest Movers From Yesterday,2019-09-26 04:34:00-04:00,LCI,neutral
753212.0,34 Stocks Moving In Wednesday's Mid-Day Session,2019-09-25 12:02:00-04:00,LCI,neutral
753213.0,Mid-Day Market Update: SYNNEX Surges On Upbeat Q3 Results; Lannett Shares Plummet,2019-09-25 12:00:00-04:00,LCI,positive
753214.0,Mid-Morning Market Update: Markets Mixed; Nike Beats Q1 Estimates,2019-09-25 10:16:00-04:00,LCI,neutral
753215.0,Lannett shares are trading lower after the company priced $75 million of convertible senior notes which are due by 2026.,2019-09-25 08:46:00-04:00,LCI,neutral
753216.0,23 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-25 08:17:00-04:00,LCI,neutral
753217.0,24 Stocks Moving in Wednesday's Pre-Market Session,2019-09-25 07:46:00-04:00,LCI,neutral
753218.0,Lannett Announces pricing Of $75M Of Convertible Senior Notes Due 2026,2019-09-25 07:41:00-04:00,LCI,neutral
753219.0,Lannett shares are trading lower after the company announced a $75 million convertible senior notes offering due 2026.,2019-09-24 16:19:00-04:00,LCI,neutral
753220.0,Lannett Announces Offering Of $75M Of Convertible Senior Notes Due 2026,2019-09-24 16:17:00-04:00,LCI,neutral
753221.0,Lannett Co shares are trading lower. This could potentially be profit taking from investors as the stock has rallied approximately 80% over the past 30 days.,2019-09-19 11:55:00-04:00,LCI,positive
753222.0,"Jim Cramer Weighs In On Centene, Fastly And More",2019-09-18 11:52:00-04:00,LCI,neutral
753223.0,"SunTrust Robinson Humphrey Maintains Hold on Lannett, Raises Price Target to $14",2019-09-18 08:56:00-04:00,LCI,neutral
753224.0,Stocks That Hit 52-Week Highs On Friday,2019-09-13 14:58:00-04:00,LCI,neutral
753225.0,Lannett shares are trading higher on continued momentum since the company reported better-than-expected Q4 results and issued FY20 sales guidance above analyst estimates in late August. The stock has increased roughly 150% since August 27th.,2019-09-13 11:01:00-04:00,LCI,positive
753226.0,24 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-13 08:44:00-04:00,LCI,neutral
753227.0,71 Biggest Movers From Yesterday,2019-09-12 05:33:00-04:00,LCI,neutral
753228.0,Lannet Co shares are trading higher on above-average volume with seemingly no company-specific news. The stock is currently trading at the 52-week high.,2019-09-11 14:53:00-04:00,LCI,neutral
753229.0,26 Stocks Moving in Wednesday's Pre-Market Session,2019-09-11 07:59:00-04:00,LCI,neutral
753230.0,64 Biggest Movers From Friday,2019-09-09 05:43:00-04:00,LCI,neutral
753231.0,Stocks That Hit 52-Week Highs On Friday,2019-09-06 12:23:00-04:00,LCI,neutral
753232.0,46 Stocks Moving In Friday's Mid-Day Session,2019-09-06 12:09:00-04:00,LCI,neutral
753233.0,"Lannett shares are trading higher after a company insider bought 25,000 shares at an average price of $9.82 per shares. When an insider buys shares, the market may perceive it as a sign of confidence in the company's outlook.",2019-09-06 11:39:00-04:00,LCI,positive
753234.0,32 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-03 08:42:00-04:00,LCI,neutral
753235.0,65 Biggest Movers From Friday,2019-09-03 05:14:00-04:00,LCI,neutral
753236.0,70 Biggest Movers From Yesterday,2019-08-30 04:05:00-04:00,LCI,neutral
753237.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-08-29 12:04:00-04:00,LCI,neutral
753238.0,"A Look At Benzinga Pro's Most-Searched Tickers For August 29, 2019",2019-08-29 11:59:00-04:00,LCI,neutral
753239.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thursday., August 29, 2019",2019-08-29 10:00:00-04:00,LCI,positive
753240.0,"SunTrust Robinson Humphrey Maintains Hold on Lannett, Raises Price Target to $10",2019-08-29 08:57:00-04:00,LCI,neutral
753241.0,54 Biggest Movers From Yesterday,2019-08-29 05:11:00-04:00,LCI,neutral
753242.0,Mid-Afternoon Market Update: Dow Surges Over 200 Points; Phibro Animal Health Shares Plummet,2019-08-28 15:33:00-04:00,LCI,positive
753243.0,"A Look At Benzinga Pro's Most-Searched Tickers For August 28, 2019",2019-08-28 14:33:00-04:00,LCI,neutral
753244.0,BMO Says 'Questions Still Remain' About Lannett Following Earnings Pop,2019-08-28 12:32:00-04:00,LCI,neutral
753245.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-08-28 12:28:00-04:00,LCI,neutral
753246.0,"Raymond James Maintains Market Perform On Lannett As Firm Notes 'Despite the loss of its golden levothyroxine goose, new management continues to dress LCI to impress delivering record base (ex-levo) revenue and the fourth consecutive top line increase'",2019-08-28 12:13:00-04:00,LCI,positive
753247.0,Mid-Day Market Update: Movado Falls After Q2 Results; Lannett Shares Jump,2019-08-28 12:00:00-04:00,LCI,positive
753248.0,Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Beat Estimates,2019-08-28 10:12:00-04:00,LCI,neutral
753249.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wednesday., August 28, 2019",2019-08-28 09:37:00-04:00,LCI,positive
753250.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-28 08:52:00-04:00,LCI,neutral
753251.0,30 Stocks Moving in Wednesday's Pre-Market Session,2019-08-28 08:11:00-04:00,LCI,neutral
753252.0,Lannett shares are trading higher after the company reported better-than-expected Q4  results and issued FY20 sales guidance above analyst estimates. The company also announced a distribution agreement with Sinotherapeutics.,2019-08-28 07:16:00-04:00,LCI,positive
753253.0,Lannett Enters Into Distribution Agreement With Sinotherapeutics For Posaconazole Delayed-Release Tablets,2019-08-28 06:55:00-04:00,LCI,positive
753254.0,Lannett Spikes Higher After Big Q4 Earnings Beat,2019-08-27 16:26:00-04:00,LCI,neutral
753255.0,Lannett shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY20 sales guidance above analyst estimates.,2019-08-27 16:19:00-04:00,LCI,positive
753256.0,Lannett Company Sees FY20 Sales $525M-$545M vs $505.95M Est.,2019-08-27 16:18:00-04:00,LCI,neutral
753257.0,"Lannett Q4 Adj. EPS $0.37 Beats $0.21 Estimate, Sales $133.84M Beat $121.68M Estimate",2019-08-27 16:17:00-04:00,LCI,neutral
753258.0,Q4 Earnings Outlook For Lannett,2019-08-27 07:36:00-04:00,LCI,neutral
753259.0,"Earnings Scheduled For August 27, 2019",2019-08-27 04:12:00-04:00,LCI,neutral
753260.0,Lannett Option Alert: Dec 20 $10 Calls Sweep (6) near the Ask: 1000 @ $0.6 vs 5786 OI; Earnings 8/27 After Close [est] Ref=$6.4,2019-08-06 11:35:00-04:00,LCI,positive
753261.0,Lannett Option Alert: Sep 20 $10 Calls Sweep (29) near the Ask: 999 @ $0.201 vs 1604 OI; Earnings 8/27 After Close [est] Ref=$6.2986,2019-07-25 13:06:00-04:00,LCI,positive
753262.0,60 Biggest Movers From Yesterday,2019-07-24 04:57:00-04:00,LCI,neutral
753263.0,Lannett Co shares are trading lower after the stock spiked yesterday on unconfirmed chatter of takeover interest in the company. The stock spiked approximately 48% yesterday.,2019-07-23 14:53:00-04:00,LCI,positive
753264.0,45 Stocks Moving In Tuesday's Mid-Day Session,2019-07-23 13:09:00-04:00,LCI,neutral
753265.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, July 23, 2019",2019-07-23 11:09:00-04:00,LCI,positive
753266.0,Lannett Option Alert: Aug 16 $7.5 Calls Sweep (23) near the Ask: 691 @ $0.6 vs 2453 OI; Earnings 8/27 After Close [est] Ref=$7.22,2019-07-23 10:31:00-04:00,LCI,positive
753267.0,Lannett Option Alert: Aug 16 $7.5 Calls Sweep (23) near the Bid: 1052 @ $0.805 vs 2453 OI; Earnings 8/27 After Close [est] Ref=$7.53,2019-07-23 09:48:00-04:00,LCI,positive
753268.0,58 Biggest Movers From Yesterday,2019-07-23 05:39:00-04:00,LCI,neutral
753269.0,42 Stocks Moving In Monday's Mid-Day Session,2019-07-22 12:41:00-04:00,LCI,neutral
753270.0,"Lannett Shares Trading ~8% Higher, Hearing Vague, Unconfirmed Chatter Of Takeover Interest In Co.",2019-07-22 10:07:00-04:00,LCI,positive
753271.0,Lannett Option Alert: Fri $5 Calls Sweep (16) near the Ask: 500 @ $0.801 vs 3085 OI; Earnings 8/27 After Close [est] Ref=$5.705,2019-07-16 14:28:00-04:00,LCI,positive
753272.0,Option Trader Makes Bullish Bet On Lannett Rebound,2019-07-16 13:42:00-04:00,LCI,neutral
753273.0,Lannett Option Alert: Sep 20 $7.5 Calls Sweep (5) near the Ask: 752 @ $0.451 vs 4841 OI; Earnings 8/27 After Close [est] Ref=$5.72,2019-07-16 09:43:00-04:00,LCI,positive
753274.0,Lannett Option Alert: Sep 20 $7.5 Calls Sweep (29) near the Ask: 854 @ $0.45 vs 4841 OI; Earnings 8/27 After Close [est] Ref=$5.83,2019-07-16 09:37:00-04:00,LCI,positive
753275.0,"Lannett to Distribute Cediprof's Levothyroxine Sodium Tablets, Lannett to Make a $20M Upfront Payment",2019-07-08 06:53:00-04:00,LCI,neutral
753276.0,"Lannett Enters Distribution Deal For Dantrolene Caps, Begins Product Launch",2019-06-28 06:54:00-04:00,LCI,neutral
753277.0,Guy Gentile Issues Open Letter to Lannett Stockholders,2019-06-26 20:27:00-04:00,LCI,neutral
753278.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-06-18 08:29:00-04:00,LCI,neutral
753279.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Fed Meeting,2019-06-18 07:22:00-04:00,LCI,positive
753280.0,"7 Stocks To Watch For June 18, 2019",2019-06-18 04:45:00-04:00,LCI,neutral
753281.0,5 Stocks Moving In Monday's After-Hours Session,2019-06-17 16:47:00-04:00,LCI,neutral
753282.0,UPDATE: Lannett Sees Incurring ~$5M In Costs To Implement Cody API Restructuring Plan,2019-06-17 16:21:00-04:00,LCI,neutral
753283.0,"UPDATE: Lannett Says Intends To Sell Equipment, Real Estate Utlized By Cody API Unit, Will Have Cody Labs Cease All Operations",2019-06-17 16:21:00-04:00,LCI,neutral
753284.0,Lannett 8-K Shows Co. Approved Restructuring Plan Related To Cody Labs,2019-06-17 16:20:00-04:00,LCI,positive
753285.0,Lannett Announces Initiation Of Human Clinical Trial Of Biosimilar Insulin Glargine Versus Us Lantus,2019-06-05 06:52:00-04:00,LCI,neutral
753286.0,"Lannett Announces CFO Martin Galvan Will Retire On August 30, 2019",2019-05-24 07:02:00-04:00,LCI,neutral
753287.0,Lannett Reports Completion Of Purchase Of ~$30.5M Term A Loans,2019-05-21 06:53:00-04:00,LCI,neutral
753288.0,Lannett Highlights Commencement Of Marketing For Generic Adderall,2019-05-16 07:09:00-04:00,LCI,neutral
753289.0,50 Biggest Movers From Yesterday,2019-05-14 05:39:00-04:00,LCI,neutral
753290.0,42 Stocks Moving In Monday's Mid-Day Session,2019-05-13 12:48:00-04:00,LCI,neutral
753291.0,Shares of several drug manufacturers are trading lower after the United States filed a lawsuit against Teva alleging price fixing.,2019-05-13 09:53:00-04:00,LCI,positive
753292.0,30 Stocks Moving In Monday's Pre-Market Session,2019-05-13 08:15:00-04:00,LCI,neutral
753293.0,Lannett Option Alert: Sep 20 $10 Calls Sweep (21) near the Ask: 700 @ $0.75 vs 1086 OI; Ref=$6.955,2019-05-09 11:57:00-04:00,LCI,positive
753294.0,72 Biggest Movers From Yesterday,2019-05-08 06:17:00-04:00,LCI,neutral
753295.0,64 Stocks Moving In Tuesday's Mid-Day Session,2019-05-07 12:17:00-04:00,LCI,neutral
753296.0,Lannett Option Alert: Jun 21 $7.5 Calls Sweep (26) near the Bid: 734 @ $0.9 vs 558 OI; Ref=$7.6201,2019-05-07 12:10:00-04:00,LCI,positive
753297.0,Lannett Raises FY19 Sales Guidance From $615M-$635M To $640M-$645M,2019-05-06 16:18:00-04:00,LCI,neutral
753298.0,"Lannett Co Q3 Adj. EPS $0.68 Beats $0.64 Estimate, Sales $172.794M Beat $156.16M Estimate",2019-05-06 16:17:00-04:00,LCI,neutral
753299.0,Lannett Q3 Earnings Preview,2019-05-06 09:18:00-04:00,LCI,neutral
753300.0,"Lannett To Launch Generic Concerta, AB-rated Methylphenidate Hydrochloride ER Tablets",2019-04-30 06:57:00-04:00,LCI,neutral
753301.0,"Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg",2019-03-27 08:45:00-04:00,LCI,positive
753302.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-03-20 07:38:00-04:00,LCI,neutral
753303.0,"SunTrust Robinson Humphrey Initiates Coverage On Lannett with Hold Rating, Announces $9 Price Target",2019-03-20 07:17:00-04:00,LCI,neutral
753304.0,Lannett Option Alert: Fri $10 Puts Sweep (22) near the Bid: 500 @ $1.65 vs 1858 OI; Earnings 5/6 After Close [est] Ref=$8.265,2019-03-15 12:07:00-04:00,LCI,positive
753305.0,Lannett Announces an Agreement with Elite Pharma and SunGen Pharma to be the Exclusive Distributor of Generic Adderall,2019-03-11 06:47:00-04:00,LCI,positive
753306.0,Lannett Option Alert: Mar 15 $10 Puts Sweep (33) near the Bid: 937 @ $1.8 vs 2627 OI; Ref=$8.27,2019-03-05 15:15:00-05:00,LCI,positive
753307.0,Lannett Presentation At Raymond James Conference Beginning At 1:05 p.m. EST,2019-03-05 13:03:00-05:00,LCI,neutral
753308.0,Lannett Option Alert: Jun 21 $7.5 Puts Sweep (3) near the Ask: 723 @ $0.85 vs 1873 OI; Ref=$9.02,2019-02-28 14:01:00-05:00,LCI,positive
753309.0,Lannett Option Alert: Sep 20 $7.5 Puts Sweep (26) near the Bid: 524 @ $1.2 vs 1035 OI; Ref=$9.205,2019-02-28 11:41:00-05:00,LCI,positive
753310.0,34 Stocks Moving In Thursday's Pre-Market Session,2019-02-28 08:26:00-05:00,LCI,neutral
753311.0,Lannett Option Alert: Mar 15 $10 Calls Sweep (23) near the Ask: 650 @ $0.551 vs 1947 OI; Ref=$9.3899,2019-02-25 10:26:00-05:00,LCI,positive
753312.0,Lannett Option Alert: Mar 15 $10 Puts Sweep (33) near the Bid: 974 @ $0.95 vs 1458 OI; Ref=$9.83,2019-02-19 11:26:00-05:00,LCI,positive
753313.0,LSV Asset Management Reports 5.37% Passive Stake in Lannett,2019-02-13 07:15:00-05:00,LCI,positive
753314.0,"BMO Capital Markets: Lannett Making Progress With Pipeline, Cost Savings",2019-02-07 13:31:00-05:00,LCI,positive
753315.0,Lannett shares are trading higher after the company reported Q2 EPS of $0.86 versus the $0.67 analyst estimate and revenue of $194M versus the $162M analyst estimate.,2019-02-07 08:41:00-05:00,LCI,positive
753316.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-02-07 08:10:00-05:00,LCI,neutral
753317.0,"Lannett Co shares are trading higher after the company reported Q2 EPS of $0.86, beating the $0.67 estimate and Q2 sales of $193.7M, beating the $162.43M estimate.",2019-02-06 17:27:00-05:00,LCI,negative
753318.0,8 Stocks Moving In Wednesday's After-Hours Session,2019-02-06 17:00:00-05:00,LCI,neutral
753319.0,Lannett Raises FY19 Sales Guidance From $585M-$615M To $615M-$635M vs $598.8M Estimate,2019-02-06 16:19:00-05:00,LCI,neutral
753320.0,"Lannett Co Q2 EPS $0.86 Beats $0.67 Estimate, Sales $193.7M Beat $162.43M Estimate",2019-02-06 16:18:00-05:00,LCI,neutral
753321.0,Lannett Option Alert: Feb 15 $7.5 Puts at the Ask: 700 @ $0.331 vs 438 OI; Earnings 2/6 After Close Ref=$8.63,2019-02-06 14:09:00-05:00,LCI,positive
753322.0,"Lannett Amended 13G Filing From BlackRock Shows Sharply Raised Stake From ~15K Shares At End Of Last Qtr. To ~4.77M Shares, Or 12.1% Stake",2019-01-31 14:23:00-05:00,LCI,positive
753323.0,Lannett Co. 13G Filing From DE Shaw Shows New 5.1% Stake,2019-01-28 16:19:00-05:00,LCI,neutral
753324.0,Lannett Enters Into Distribution Agreement For Trientine Hydrochloride Capsules,2019-01-22 06:57:00-05:00,LCI,positive
753325.0,Moody's Confirms Lannett's Ratings; Outlook Changed To Negative,2019-01-12 08:00:00-05:00,LCI,negative
753326.0,65 Biggest Movers From Yesterday,2019-01-08 05:16:00-05:00,LCI,neutral
753327.0,42 Stocks Moving In Monday's Mid-Day Session,2019-01-07 13:49:00-05:00,LCI,neutral
753328.0,Lannett Amended 13G Filing From MintBroker/Guy Gentile Shows Raised Stake To 8.61%,2019-01-03 16:21:00-05:00,LCI,neutral
753329.0,Raymond James: Lannett Emerges From Levothyroxine Woes,2018-12-13 15:26:00-05:00,LCI,negative
753330.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Dec. 12, 2018",2018-12-12 12:49:00-05:00,LCI,positive
753331.0,Lannett Announces Amendment To Credit Agreement,2018-12-11 07:44:00-05:00,LCI,positive
753332.0,Lannett Option Alert: Dec 21 $5 Calls Sweep (4) near the Ask: 704 @ $0.5 vs 3117 OI; Ref=$5.47,2018-12-06 16:00:00-05:00,LCI,positive
753333.0,27 Stocks Moving In Thursday's Pre-Market Session,2018-11-29 08:02:00-05:00,LCI,neutral
753334.0,54 Stocks Moving In Monday's Mid-Day Session,2018-11-12 12:38:00-05:00,LCI,neutral
753335.0,25 Stocks Moving In Monday's Pre-Market Session,2018-11-12 08:18:00-05:00,LCI,neutral
753336.0,Lannett to Receive $50M Upfront Payment From Amneal Pharma for Exclusive Distribution of Levothyroxine Sodum,2018-11-12 06:55:00-05:00,LCI,positive
753337.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Nov. 9, 2018",2018-11-09 10:02:00-05:00,LCI,positive
753338.0,80 Biggest Movers From Yesterday,2018-11-09 05:18:00-05:00,LCI,neutral
753339.0,"Activist Investor Guy Gentile Tells Benzinga He Is Not Selling Lannett Shares Off Of Today's Move, Says He Added More Shares Today",2018-11-08 12:05:00-05:00,LCI,negative
753340.0,Lannett Co Sees FY19 Sales $585M-$615M vs $591.62M Est.,2018-11-07 16:19:00-05:00,LCI,neutral
753341.0,"Lannett Co Inc Q1 Adj. EPS $0.44 Beats $0.39 Estimate, Sales $155.1M Beat $145.79M Estimate",2018-11-07 16:18:00-05:00,LCI,neutral
753342.0,"Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products",2018-11-06 06:54:00-05:00,LCI,positive
753343.0,Lannett Enters Into Distribution Agreement For Vardenafil Hydrochloride Tablets,2018-11-01 08:21:00-04:00,LCI,positive
753344.0,Lannett Reports Distribution Deal For Vardenafil Hydrochloride Tablets,2018-11-01 06:52:00-04:00,LCI,neutral
753345.0,"Stocks Which Set New 52-Week Low Friday, October 26th",2018-10-29 09:56:00-04:00,LCI,negative
753346.0,"Lannett Announces Plan to Sell Cody API Business, Resulting in ~$18M Reduction to Company's Operating Expenses on an Annualized Basis",2018-10-26 18:45:00-04:00,LCI,neutral
753347.0,Lannett to be the Exclusive US Distribution Partner for Adare Pharma,2018-10-22 06:56:00-04:00,LCI,positive
753348.0,Lannett shares are up 22.8% after hours on low volume; Not currently seeing any company-specific news.,2018-10-11 17:01:00-04:00,LCI,neutral
753349.0,"Stocks Which Set New 52-Week Low Yesterday, October 9th",2018-10-10 11:01:00-04:00,LCI,negative
753350.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-10-09 12:39:00-04:00,LCI,neutral
753351.0,44 Biggest Movers From Yesterday,2018-10-09 05:27:00-04:00,LCI,neutral
753352.0,Lannett Tumbles After Engaging Strategic Advisors,2018-10-08 15:29:00-04:00,LCI,positive
753353.0,Lannett Amended 8-K From Friday Shows Co. Expects ~$339.6M Impairment Charge To Goodwill Related To Previously Disclosed Nonrenewal Of Co.'s Distribution Agreement With Jerome Stevens Pharmaceuticals; Charge Results In Full Impairment Of Co.'s Goodwill,2018-10-08 14:20:00-04:00,LCI,positive
753354.0,"Activist Investor Guy Gentile Responds To Lannett Engaging Advisors, Tells Benzinga He Thinks 'Based On Who LCI Hired, Looks Like A Sale Is Likely Around $8'",2018-10-08 14:10:00-04:00,LCI,positive
753355.0,"Lannett Reports Engaging Of Advisors To Explore, Evaluate Debt, Capital Structure Alternatives",2018-10-08 09:31:00-04:00,LCI,neutral
753356.0,Activist Investor Guy Gentile Increases Stake In Lannett,2018-10-05 09:39:00-04:00,LCI,neutral
753357.0,"Activist Investor Guy Gentile Tells Benzinga He Has Added To His Stake In Lannett Since The Filing On Sep. 20, 2018, From ~1.99M Shares To 'Over 2.5M Shares,' Says 'Will Keep Adding' To Stake",2018-10-05 07:47:00-04:00,LCI,positive
753358.0,56 Biggest Movers From Yesterday,2018-09-21 04:48:00-04:00,LCI,neutral
753359.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-09-20 12:31:00-04:00,LCI,neutral
753360.0,Lannett Shares Up 10% Premarket Following 13G Filing Wed. Evening Showing New 5.12% Stake From MintBroker/Guy Gentile,2018-09-20 08:59:00-04:00,LCI,positive
753361.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-09-20 08:15:00-04:00,LCI,neutral
753362.0,Lannett Co. Sees FY19 Sales $580M-$610M vs $635M Est.,2018-08-28 16:18:00-04:00,LCI,neutral
753363.0,"Lannett Co Q4 Adj. EPS $0.64, Inline, Sales $170.9M Miss $171.45M Estimate",2018-08-28 16:16:00-04:00,LCI,negative
753364.0,"Earnings Scheduled For August 28, 2018",2018-08-28 04:07:00-04:00,LCI,neutral
753365.0,"Stocks Which Set New 52-Week Low Yesterday, August 23rd",2018-08-24 09:12:00-04:00,LCI,negative
753366.0,42 Biggest Movers From Yesterday,2018-08-24 04:13:00-04:00,LCI,neutral
753367.0,41 Stocks Moving In Thursday's Mid-Day Session,2018-08-23 12:42:00-04:00,LCI,neutral
753368.0,"Stocks Which Set New 52-Week Low Yesterday, Augst 22nd",2018-08-23 11:15:00-04:00,LCI,negative
753369.0,Lannett Downgraded By Raymond James After Loss Of Drug Distribution Deal,2018-08-21 14:34:00-04:00,LCI,negative
753370.0,"Benzinga's Top Upgrades, Downgrades For August 21, 2018",2018-08-21 09:26:00-04:00,LCI,positive
753371.0,Raymond James Downgrades Lannett to Market Perform,2018-08-21 06:07:00-04:00,LCI,neutral
753372.0,41 Biggest Movers From Yesterday,2018-08-21 04:47:00-04:00,LCI,neutral
753373.0,Mid-Afternoon Market Update: Dow Up Over 100 Points; Seven Stars Cloud Shares Spike Higher,2018-08-20 14:32:00-04:00,LCI,positive
753374.0,Craig-Hallum Downgrades Lannett to Hold,2018-08-20 12:58:00-04:00,LCI,neutral
753375.0,28 Stocks Moving In Monday's Mid-Day Session,2018-08-20 12:35:00-04:00,LCI,neutral
753376.0,Mid-Day Market Update: Cheetah Mobile Rises Following Q2 Results; Lannett Shares Plunge,2018-08-20 12:11:00-04:00,LCI,positive
753377.0,Mid-Morning Market Update: Markets Mostly Higher; PepsiCo To Buy SodaStream For $3.2 Billion,2018-08-20 10:10:00-04:00,LCI,neutral
753378.0,Roth Capital Downgrades Lannett to Neutral,2018-08-20 10:08:00-04:00,LCI,neutral
753379.0,"Lannett Co shares are down 56% in pre-market trading after the company issued weak guidance for Q3 and 2018, cut guidance for 2018, and announced its contract with Jerome Stevens Pharma will not be renewed.",2018-08-20 09:32:00-04:00,LCI,negative
753380.0,25 Stocks Moving In Monday's Pre-Market Session,2018-08-20 08:13:00-04:00,LCI,neutral
753381.0,Lannett Sees FY2018 EPS $3.08-3.10 vs $3.12 Est; Narrows FY2018 Sales Guidance from $685.0M-695.0M to $685.0M vs $687.18M Est,2018-08-20 06:56:00-04:00,LCI,neutral
753382.0,Lannett Sees Q4 EPS $0.62-0.64 vs $0.66 Est; Sees Sales $171.0M vs $173.53M Est,2018-08-20 06:55:00-04:00,LCI,neutral
753383.0,Lannett Says Its Contract Jerome Stevens Pharma Will Not be Renewed,2018-08-20 06:54:00-04:00,LCI,neutral
753384.0,Lannett Sees Impairment Charge Of ~$3.5M Related To Consolidation Of Co.'s Manufacturing Activities Related To Assets At Co.'s Townsend Road Facility,2018-08-06 17:36:00-04:00,LCI,positive
753385.0,"Lannett Amended 8-K Shows Co. Concluded It Expects To Report Impairment Charge Of ~$21.5M Related To Facility, Equipment, Plant-Related Assets Associated With Expansion Of Project At Cody Labs",2018-08-06 17:35:00-04:00,LCI,positive
753386.0,"UPDATE: Lannett Will Provide Sales, Marketing, Distribution Support Of Andor's Generic Concerta, For Which Co. Will Receive An Undisclosed Percentage Of Net Profits",2018-08-03 06:57:00-04:00,LCI,positive
753387.0,Lannett Reports Exclusive Perpetual License Deal For Generic Concerta With Andor Pharma,2018-08-03 06:56:00-04:00,LCI,positive
753388.0,Stocks Which Set New 52-Week Lows Yesterday:,2018-07-24 12:10:00-04:00,LCI,negative
753389.0,"UPDATE: Amneal Says Lannett Failed To Prove US Patents '237, '767 Protecting Zomig Nasal Spray Were Invalid",2018-06-29 07:38:00-04:00,LCI,negative
753390.0,Amneal Pharma Reports Favorable Ruling Related To Patent Validity For Zomig Nasal Spray,2018-06-29 07:38:00-04:00,LCI,positive
753391.0,"UPDATE: Lannett Sees Annualized Cost Savings Of ~$10M From Cody Labs Restructuring, Sees Completion By Dec. 2018, Sees Incurring ~$5M Of Total Costs To Implement Plan",2018-06-29 06:57:00-04:00,LCI,neutral
753392.0,UPDATE: Lannett Says Cody Labs Restructuring Effort Will Reduce Headcount For Cody By ~50 Positions,2018-06-29 06:55:00-04:00,LCI,neutral
753393.0,"UPDATE: Lannett Says Will Transfer Production Of Finished Dosage Liquid Pharma Products To Its Carmel, New York Facility, Discontinue Manufacturing Of Less Profitable API Products, Rationalize API Product Development Program",2018-06-29 06:54:00-04:00,LCI,positive
753394.0,Lannett Reports Restructuring Plan For Its Cody Labs Subsidiary,2018-06-29 06:53:00-04:00,LCI,neutral
753395.0,"Lannett Shares Down ~8%, Hearing That Earlier Today Deutsche Bank Said The Outcome Of The Co.'s Largest Product Revenue Producer levothyroxine Could Go Away In March 2019 If Partnership With Jerome Stevens Pharmaceuticals Is Not Extended",2018-06-18 10:10:00-04:00,LCI,positive
753396.0,Benzinga Pro's 5 Stocks To Watch Today,2018-06-01 09:07:00-04:00,LCI,neutral
753397.0,26 Stocks Moving In Friday's Pre-Market Session,2018-06-01 08:03:00-04:00,LCI,neutral
753398.0,Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated,2018-06-01 07:02:00-04:00,LCI,positive
753399.0,Lannett Receives FDA Approval For Dronabinol Capsules,2018-05-21 06:54:00-04:00,LCI,positive
753400.0,9 Stocks Moving In Monday's After-Hours Session,2018-05-07 17:06:00-04:00,LCI,neutral
753401.0,Lannett Cuts FY18 Adj. Sales Outlook From $680M-$700M to $685M-$695M,2018-05-07 16:19:00-04:00,LCI,negative
753402.0,"Lannett Co Q3 EPS $0.80 Beats $0.79 Estimate, Sales $174.4M Miss $176.33M Estimate",2018-05-07 16:18:00-04:00,LCI,negative
753403.0,"Lannett Acquires a Portfolio of Generic Drugs from Endo International, Terms Not Disclosed",2018-05-07 07:02:00-04:00,LCI,neutral
753404.0,24 Stocks Moving In Monday's Pre-Market Session,2018-04-23 08:02:00-04:00,LCI,neutral
753405.0,Lannett Announces 2 Agreements to Resell Products from Diclofenac ER and Fluvastatin ER and an Agreement for Pharmaceutical Associates to Repackage 5 Products,2018-03-12 06:55:00-04:00,LCI,positive
753406.0,Lannett Filing Shows Registration For Mixed Securities Shelf Offering,2018-02-13 17:03:00-05:00,LCI,positive
753407.0,46 Biggest Movers From Yesterday,2018-02-09 04:36:00-05:00,LCI,neutral
753408.0,Lannett Shares Down 11.3% After Wednesday Cutting FY18 Sales Guidance,2018-02-08 12:25:00-05:00,LCI,positive
753409.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-02-08 12:25:00-05:00,LCI,neutral
753410.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-02-08 08:03:00-05:00,LCI,neutral
753411.0,Lannett Cuts FY18 Sales Guidance From $710M-$720M To $680M-$700M vs $720.9M Est.,2018-02-07 16:24:00-05:00,LCI,negative
753412.0,"Lannett Reports Q2 Adj. EPS $1.06 vs $0.85 Est., Sales $184.3M vs $191.8M Est.",2018-02-07 16:23:00-05:00,LCI,neutral
753413.0,Lannett Reports Entered Into Consulting Deal With Former CEO,2018-02-01 06:58:00-05:00,LCI,neutral
753414.0,"Goldman Sachs Initiates Coverage On Lannett with Neutral Rating, Announces $21.00 Price Target",2018-01-24 08:28:00-05:00,LCI,neutral
753415.0,38 Biggest Movers From Yesterday,2017-12-22 05:50:00-05:00,LCI,neutral
753416.0,36 Stocks Moving In Thursday's Mid-Day Session,2017-12-21 12:17:00-05:00,LCI,neutral
753417.0,Lannett Names Timothy Crew CEO,2017-12-21 06:55:00-05:00,LCI,neutral
753418.0,Lannett Reports FDA Acceptance Of 505(b)(2) NDA For Cocaine Hydrochloride Topical Solution,2017-12-01 06:53:00-05:00,LCI,positive
753419.0,Lannet Announces Agreement With Aralez Pharma For Authorized Generic Version of Toprol-XL,2017-11-29 16:48:00-05:00,LCI,positive
753420.0,"Thor Industries Shares Up 13% Following Strong Q1 Results; Winnebago Shares Up 7.6% In Sympathy, Lannett Shares Up 2.4%, Patrick Industries Shares Up 2%",2017-11-28 09:45:00-05:00,LCI,positive
753421.0,4 Q3 Earnings Winners Breaking Out,2017-11-08 12:56:00-05:00,LCI,positive
753422.0,56 Biggest Movers From Yesterday,2017-11-08 04:40:00-05:00,LCI,neutral
753423.0,45 Stocks Moving In Tuesday's Mid-Day Session,2017-11-07 12:41:00-05:00,LCI,neutral
753424.0,Lannett Increases FY17 Sales From $655-$665M To $710-$720M,2017-11-06 16:17:00-05:00,LCI,neutral
753425.0,"Lannett Reports Q1 EPS $0.60 vs $0.52 Est., Sales $155M vs $153M Est.",2017-11-06 16:17:00-05:00,LCI,neutral
753426.0,Lannett Offers Comment On Amended Civil Complaint: 'Lannett has reviewed the complaint and believes the price fixing allegations regarding the single product named in the complaint that Lannett sells are meritless',2017-11-01 06:56:00-04:00,LCI,negative
753427.0,46 Biggest Movers From Yesterday,2017-11-01 05:27:00-04:00,LCI,neutral
753428.0,Lannett Shares Down 12% Tues. Afternoon Following Earlier Report 46 States Will Expand A Suit Related To Price-Fixing Allegations By Generic Drugmakers,2017-10-31 13:31:00-04:00,LCI,positive
753429.0,Lannett Option Alert: Jan 19 $22.5 Calls Sweep (2) at the Ask: 620 @ $2.4 vs 1881 OI; Ref=$21.75,2017-10-31 11:39:00-04:00,LCI,positive
753430.0,"Lannett and Celgene Announces a Licensing Agreement Related to Celgene's Thalomid, Lannett to Manufacture a Generic Version of the Drug in 2019",2017-10-30 06:54:00-04:00,LCI,positive
753431.0,Lannett Receives 2 FDA Approvals For Lansoprazole Delayed-Release Capsules USP,2017-10-02 06:59:00-04:00,LCI,neutral
753432.0,"UPDATE: Lannett Says Co. Is Cleared To Market Prescription, OTC Generic Prevacid",2017-10-02 06:58:00-04:00,LCI,positive
753433.0,Lannett Reports Received 2 FDA Approvals For Lansoprazole Delayed-Release Capsules,2017-10-02 06:57:00-04:00,LCI,neutral
753434.0,"Noticing Weakness In Several Generic Names Thurs.: Impax Labs Down 8%, Lannett Shares Down 4.4%; Not Seeing Any News To Justify Price Action; However, Lannett Shares Were Up 9% On Wed. Amid FDA Approval For Oxycodone, Acetaminophen Tablets",2017-09-28 15:53:00-04:00,LCI,positive
753435.0,"A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Economic Reports, Fed Speakers",2017-09-27 07:38:00-04:00,LCI,neutral
753436.0,Lannett Receives FDA Approval For Oxycodone And Acetaminophen Tablets,2017-09-27 06:52:00-04:00,LCI,positive
753437.0,Lannett's Abbreviated NDA for Dexmethylphenidate Hydrochloride Tablets is Approved by the FDA,2017-09-26 06:54:00-04:00,LCI,positive
753438.0,Lannett Announces Class Action Lawsuit Against Generic Drug Manufacturers was Dismissed by the Eastern District of Pennsylvania,2017-09-26 06:41:00-04:00,LCI,negative
753439.0,Lannett Announces the Search for a New CEO,2017-09-25 06:54:00-04:00,LCI,neutral
753440.0,"Lannett Announces FDA Approval of its Abbreviated NDA For Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg And 40 mg",2017-09-05 06:54:00-04:00,LCI,positive
753441.0,"Lannett Company Reports Q4 Adj. EPS $0.40 vs $0.55 Est., Sales $139.1M vs $149.3M Est.",2017-08-23 16:25:00-04:00,LCI,neutral
753442.0,Lannett Sees FY18 Sales $655M-$665M vs $646.5M Est.,2017-08-23 16:25:00-04:00,LCI,neutral
753443.0,"Earnings Scheduled For August 23, 2017",2017-08-23 04:48:00-04:00,LCI,neutral
753444.0,CORRECTION: Lannett Does Not Give Q4 Sales,2017-08-08 06:58:00-04:00,LCI,neutral
753445.0,Lannett Sees Q4 EPS $0.37-0.40 vs $0.75 Est,2017-08-08 06:57:00-04:00,LCI,neutral
753446.0,"Lannett Reports Received Approval For Cyproheptadine Hydrochloride Syrup, 2mg/5 mL",2017-07-14 06:53:00-04:00,LCI,positive
753447.0,Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets,2017-06-26 06:59:00-04:00,LCI,positive
753448.0,Lannett's Abbreviated New Drug Application for Hydrocodone Bitartrate and Acetaminophen Tablets USP is Approved by the FDA,2017-06-22 06:54:00-04:00,LCI,positive
753449.0,Lannett Receives Approval For Niacin Extended-Release Tablets,2017-06-19 07:00:00-04:00,LCI,positive
753450.0,"Lannett's NDA for Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL Approved by FDA",2017-05-16 06:53:00-04:00,LCI,positive
753451.0,"Lannett Files For Mixed Shelf Offering, Size Not Disclosed",2017-05-12 17:24:00-04:00,LCI,neutral
753452.0,15 Biggest Mid-Day Losers For Wednesday,2017-05-03 12:59:00-04:00,LCI,negative
753453.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-05-03 08:05:00-04:00,LCI,neutral
753454.0,"Lannett Reports Q3 Adj. EPS $0.77 vs $0.87 Est., Adj. Sales $165.7M vs $170.5M Est.",2017-05-02 16:17:00-04:00,LCI,neutral
753455.0,Lannett Says FDA Suspends Deadline For Co. To Submit Materials In Requset For A Hearing To Consider FDA's Proposal That Lannett Withdraw Its Abbreviated New Drug Application For Methylphenidate ER,2017-02-22 06:56:00-05:00,LCI,neutral
753456.0,Strong Earnings Numbers Ramp Up Pressure For Possible Lannett Short Squeeze,2017-02-02 12:24:00-05:00,LCI,positive
753457.0,Lannett Sees FY17 Rev. $675-$685M vs. Est. $673M,2017-02-01 16:17:00-05:00,LCI,neutral
753458.0,"Lannett Reports Q2 EPS $0.92 vs. Est. $0.84, Rev. $170.9M vs. Est. $169M",2017-02-01 16:16:00-05:00,LCI,neutral
753459.0,"Citron On Lannett: Price Gouging At Its Worst, Will Be First To Go Bankrupt",2017-01-17 12:26:00-05:00,LCI,negative
753460.0,Option Alert: Lannett Jan 20.0 Puts Sweep: 500 @  ASK  $1.50: 1654 traded vs 1313 OI:  Earnings 2/2 After Close (est)  $18.85 Ref,2017-01-17 12:02:00-05:00,LCI,positive
753461.0,Citron Research @CitronResearch now Citron exposes the lawsuits that will drive Lannett (LCI) to 0.  Price gouging and leverage at its worst in pharma.  citronrsearch.com,2017-01-17 11:42:00-05:00,LCI,negative
753462.0,Lannet Announces FDA Approval For Lopinavir And Ritonavir Oral Solution,2017-01-03 13:13:00-05:00,LCI,positive
753463.0,"Lannett Gets Supplemental Approval For Morphine Sulfate Oral Solution CII, 20 mg/mL",2016-12-19 06:57:00-05:00,LCI,positive
753464.0,First Charges Filed in Generic Drug Price Probe: Connected Stocks Sell Off,2016-12-14 13:32:00-05:00,LCI,negative
753465.0,"Weakness in Several Pharma Names Being Attributed to Bloomberg Report Lannett, Impax, Endo, Taro, Actavis, Covis, Sun Pharma, Mayne Received Subpoenas",2016-12-14 12:15:00-05:00,LCI,negative
753466.0,Andy Biotech Tweets: $LCI should also be at the center of this probe on generic drug price fixing,2016-12-14 11:49:00-05:00,LCI,neutral
753467.0,"Lannett Provides Update On Methylphenidate ER Tablets, Granted 90-Day Extension",2016-11-30 06:56:00-05:00,LCI,positive
753468.0,A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street,2016-11-28 07:39:00-05:00,LCI,negative
753469.0,"Lannett Announces Approval For Metaxalone Tablets USP, 800 Mg",2016-11-28 06:54:00-05:00,LCI,positive
753470.0,"Lannett Announces Approval For Memantine Hydrochloride Tablets USP, 5 mg And 10 mg",2016-11-14 06:56:00-05:00,LCI,positive
753471.0,Snow Capital Reports 5.7% Passive Stake In Lannett Co. 13G Filing,2016-11-09 09:45:00-05:00,LCI,positive
753472.0,"Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks",2016-11-04 13:53:00-04:00,LCI,negative
753473.0,Lannett Cuts FY17 Sales Guidance from $690M-$700M to $675M-$685M vs $683M Est.,2016-11-03 16:56:00-04:00,LCI,negative
753474.0,"Lannett Reports Q1 EPS $0.77 vs. Est. $0.71, Rev. $161.6M vs. Est. $166M",2016-11-03 16:21:00-04:00,LCI,neutral
753475.0,"Hearing Dept. of Justice is Probing Generic Cos., Mylan, Teva, Actavis, Impax, Endo's Par, Covis, Lannett, Others Received Subpoenas",2016-11-03 14:14:00-04:00,LCI,positive
753476.0,Lannett Phase III Trial For C-Topical Met All Primary Endpoints,2016-10-27 06:51:00-04:00,LCI,neutral
753477.0,Lannett Says FDA to Withdraw Approval of Abbreviated New Drug Application,2016-10-19 06:58:00-04:00,LCI,positive
753478.0,Technical Alert: Lannett Co. Breaches Lower-End Of Trading Range,2016-10-17 11:45:00-04:00,LCI,positive
753479.0,Lannett Gets FDA Approval For Buprenorphine and Nalozone Tablets,2016-09-20 06:57:00-04:00,LCI,positive
753480.0,"After-Hours Losers Aug. 24, 2016: HPQ Down 5.4%, LCI 3.4%",2016-08-24 18:25:00-04:00,LCI,negative
753481.0,Wednesday's Market Wrap: Stocks Pull Back Mid-Week,2016-08-24 17:03:00-04:00,LCI,neutral
753482.0,18 Biggest Mid-Day Gainers For Wednesday,2016-08-24 12:56:00-04:00,LCI,neutral
753483.0,Mid-Day Market Update: Lannett Gains On Strong Results; Dycom Industries Shares Slide,2016-08-24 12:14:00-04:00,LCI,positive
753484.0,Benzinga's Volume Movers,2016-08-24 10:37:00-04:00,LCI,neutral
753485.0,Mid-Morning Market Update: Markets Mostly Lower; Express Misses Q2 Views,2016-08-24 10:07:00-04:00,LCI,negative
753486.0,14 Stocks Moving In Wednesday's Pre-Market Session,2016-08-24 08:28:00-04:00,LCI,neutral
753487.0,6 Stocks Moving After Hours: From Earnings To Government Contracts,2016-08-23 17:51:00-04:00,LCI,neutral
753488.0,Lannett Sees FY17 Sales $690M-$700M vs $666.1M Est.,2016-08-23 16:17:00-04:00,LCI,neutral
753489.0,"Lannett Reports Q4 Adj. EPS $0.73 vs $0.59 Est., Sales $168.9M vs $161.6M Est.",2016-08-23 16:16:00-04:00,LCI,neutral
753490.0,"Earnings Scheduled For August 23, 2016",2016-08-23 04:04:00-04:00,LCI,neutral
753491.0,Lannett Gets FDA Acceptable Filing Letter For Fentanyl Patch ANDA,2016-07-20 09:51:00-04:00,LCI,positive
753492.0,Lannett Announces Receipt Of FDA Acceptable Filing Letter For Fentanyl Patch ANDA,2016-07-20 06:57:00-04:00,LCI,positive
753493.0,Lannett Gets FDA Approval To Launch Paroxetine Extended Release Tablets,2016-07-11 08:38:00-04:00,LCI,positive
753494.0,"Lannett Announces Approval And Launch Of Paroxetine Extended Release Tablets USP, 12.5 Mg, 25 Mg, 37.5 Mg",2016-07-11 06:54:00-04:00,LCI,positive
753495.0,A Fairly Balanced Risk And Reward Scenario For Lannett; Deutsche Bank Initiates At Hold,2016-06-29 11:30:00-04:00,LCI,positive
753496.0,Benzinga's Top Initiations,2016-06-29 09:30:00-04:00,LCI,positive
753497.0,Deutsche Bank Initiates Coverage on Lannett at Hold,2016-06-29 07:06:00-04:00,LCI,neutral
753498.0,10 Biggest Mid-Day Gainers For Tuesday,2016-06-28 12:33:00-04:00,LCI,neutral
753499.0,10 Stocks Moving In Tuesday's Pre-Market Session,2016-06-28 08:20:00-04:00,LCI,neutral
753500.0,A Peek Into The Markets: U.S. Stock Futures Point To Lower Start For Wall Street,2016-06-13 07:48:00-04:00,LCI,negative
753501.0,Lannett Gets FDA Approval For Neomycin Sulfate Tablets,2016-06-13 07:34:00-04:00,LCI,positive
753502.0,"Lannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg",2016-06-13 06:58:00-04:00,LCI,positive
753503.0,"Susquehanna Says VRX Bid From TPG/TAKEDA May Put A Floor Under ENDP, LCI, AKRX",2016-05-31 08:58:00-04:00,LCI,neutral
753504.0,Lannett Completes Senior Notes Pay Down Of $50 Million,2016-05-27 12:41:00-04:00,LCI,negative
753505.0,Lannett Shares Rally at Open as Hearing Craig Hallum Has Said Co. Contract with CVS is 'Back On',2016-05-23 09:40:00-04:00,LCI,positive
753506.0,"Lannett Reports Q3 Adj. EPS $0.75 vs $0.63 Est., Sales $163.7M vs $161.6M Est.",2016-05-03 16:17:00-04:00,LCI,neutral
753507.0,Lannett Announces Will Co-Develop Generic Insulin Product,2016-04-22 06:54:00-04:00,LCI,neutral
753508.0,Lannett Announces Departure of President Michael Bogda,2016-04-11 16:33:00-04:00,LCI,neutral
753509.0,Lannett Announces FDA Approval of 2 NDAs,2016-03-29 06:57:00-04:00,LCI,positive
753510.0,Stocks Hitting 52-Week Lows,2016-03-24 10:15:00-04:00,LCI,negative
753511.0,"Roth Capital Maintains Buy on Lannett, Lowers PT to $27.50",2016-03-24 08:08:00-04:00,LCI,negative
753512.0,"Canaccord Genuity Downgrades Lannett to Sell, Lowers PT to $18.00",2016-03-24 05:48:00-04:00,LCI,negative
753513.0,Lannett Sees FY16 Rev. $555-$565M vs. Est. $716M,2016-03-23 16:16:00-04:00,LCI,neutral
753514.0,Lannett Cuts FY16 Guidance,2016-03-23 16:15:00-04:00,LCI,negative
753515.0,"Lannett Closes Green Day, Still Down 51% YTD",2016-03-22 16:51:00-04:00,LCI,neutral
753516.0,Stocks Hitting 52-Week Lows,2016-03-14 10:06:00-04:00,LCI,negative
753517.0,Lannett Says Revisiting 2016 Sales Guidance Due to Market Weakness,2016-03-14 06:04:00-04:00,LCI,negative
753518.0,"Roth Capital Maintains Buy on Lannett, Lowers PT to $3.00",2016-03-11 07:56:00-05:00,LCI,negative
753519.0,"Lannett Enters Settlement With Customer, Will Pay $8M In Cash To Customer In FY 2016, At Customer Discretion Will Pay $8M Cash Or $10M Credit In FY 2017 & $10M Cash Or $12M Credit In FY 2018",2016-03-10 18:00:00-05:00,LCI,positive
753520.0,"Lannet Company Announces FDA Approval Of Nasal Spray, Shares Tick Higher",2016-02-22 12:36:00-05:00,LCI,positive
753521.0,Lannett Announces FDA Approval for Sumatriptan Nasal Spray,2016-02-22 06:58:00-05:00,LCI,positive
753522.0,Lannett Receives FDA Approval for Temozolomide Caps,2016-02-11 06:59:00-05:00,LCI,positive
753523.0,Lannett Receives FDA Approval for Temozolomide Capsules,2016-02-11 06:58:00-05:00,LCI,positive
753524.0,Cramer Says Sell These 'Completely Untouchable' Stocks,2016-02-10 17:52:00-05:00,LCI,neutral
753525.0,Lannett Sees FY16 Rev. $585-$595M vs. Est. $591.26M,2016-02-03 16:18:00-05:00,LCI,neutral
753526.0,"Lannett Reports Q2 EPS $0.95 vs. Est. $0.94, Rev. $127.1M vs. Est. $127.2M",2016-02-03 16:17:00-05:00,LCI,neutral
753527.0,"Lannett Reports Cost Reduction Of $40M With Immediate Reduction Of 10% Of Workforce, 20% Reduction Over 3 Years",2016-02-01 16:23:00-05:00,LCI,neutral
753528.0,"Total System Services, Lannett And Fate Therapeutics Moving After-Hours",2016-01-26 17:23:00-05:00,LCI,neutral
753529.0,Lannett Sees FY16 Sales $585M-$595M vs $609.3M Est.,2016-01-26 16:17:00-05:00,LCI,neutral
753530.0,UPDATE: Lannett Sees Q2 Adj. EPS $0.93-$0.95 vs $0.98 Est.,2016-01-26 16:17:00-05:00,LCI,neutral
753531.0,Lannett Sees Q2 Sales ~$127M vs $141.6M Est.,2016-01-26 16:16:00-05:00,LCI,neutral
753532.0,UPDATE: Lannett Sees ~$40M in Cost Reductions During First 12 Months Following Closing of Kremers Urban Pharma Purchase,2015-12-21 16:20:00-05:00,LCI,neutral
753533.0,"Lannett Issues Comments on Integration Plans, Cost Reduction Initiatives",2015-12-21 16:20:00-05:00,LCI,neutral
753534.0,Lannet 13D Shows Holder UCB SA Holds 6.4% Stake,2015-12-03 16:10:00-05:00,LCI,neutral
753535.0,Craig-Hallum Downgraded Lannett to Hold,2015-11-05 10:10:00-05:00,LCI,neutral
753536.0,"Lannett Reports Q1 EPS $0.99 vs. Est. $0.89, Rev. $106.4M vs. Est. $103.9M",2015-11-04 16:16:00-05:00,LCI,neutral
753537.0,Lannett Reports Q1 Prelim Adj EPS $0.98-$0.99 Vs Est $0.88,2015-10-28 17:51:00-04:00,LCI,neutral
753538.0,Lannett Announces FDA Approval For Memantine Hydrochloride,2015-10-14 06:58:00-04:00,LCI,positive
753539.0,Benzinga's Volume Movers,2015-09-03 10:40:00-04:00,LCI,neutral
753540.0,Mid-Morning Market Update: Markets Gain; Campbell Soup Earnings Top Estimates,2015-09-03 10:29:00-04:00,LCI,positive
753541.0,Morning Market Gainers,2015-09-03 09:42:00-04:00,LCI,neutral
753542.0,Benzinga's Top #PreMarket Gainers,2015-09-03 08:14:00-04:00,LCI,positive
753543.0,Wednesday's After-Hours Movers: 7 Stocks To Watch,2015-09-03 06:39:00-04:00,LCI,neutral
753544.0,"10 Stocks To Watch For September 3, 2015",2015-09-03 04:42:00-04:00,LCI,neutral
753545.0,"Benzinga's M&A Chatter for Wednesday September 2, 2015",2015-09-02 18:55:00-04:00,LCI,neutral
753546.0,Lannett +22% After Hours Following Announcement it Will Acquire Kremers Urban Pharmaceuticals for $1.23B,2015-09-02 16:55:00-04:00,LCI,neutral
753547.0,Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23B,2015-09-02 16:30:00-04:00,LCI,neutral
753548.0,"Lannett Co. Sees FY16 Sales $425M-$435M vs $433.6M Est., Gross Margin in 71-73% Range",2015-08-25 16:05:00-04:00,LCI,negative
753549.0,"Lannett Reports Q4 EPS $0.91 Vs Est $0.86, Sales $99.3M vs Est $97.62M",2015-08-25 16:04:00-04:00,LCI,neutral
753550.0,"Earnings Scheduled For August 25, 2015",2015-08-25 04:07:00-04:00,LCI,neutral
753551.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,LCI,neutral
753552.0,"Lannett Reports Receiving of FDA Approval, Launches ABILIFY",2015-08-18 07:57:00-04:00,LCI,positive
753553.0,"Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral",2015-07-21 11:31:00-04:00,LCI,neutral
753554.0,"Susquehanna Initiates Coverage on Lannett Co at Positive, Announces $75.00 PT",2015-07-21 07:24:00-04:00,LCI,positive
753555.0,"Susquehanna Initiates Coverage on Lannett Co at Positive, Announces $75.00 PT",2015-07-20 16:44:00-04:00,LCI,positive
753556.0,Lannett Announces Amendment to Bylaws Will Repeak Fee Shifting Provision,2015-07-09 16:30:00-04:00,LCI,neutral
753557.0,Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere,2015-06-03 17:05:00-04:00,LCI,neutral
753558.0,"Raymond James Initiates Coverage on Lannett Co at Outperform, Announces $63.00 PT",2015-06-03 06:30:00-04:00,LCI,neutral
753559.0,5 NYSE Healthcare Stocks With The Highest Operating Margin,2015-06-01 09:09:00-04:00,LCI,neutral
753560.0,"Lannett Signs Definitive Agreement To Acquire Silarx Pharmaceuticals, Inc.",2015-05-18 09:00:00-04:00,LCI,positive
753561.0,"Lannett Reports Q3 EPS $0.97 vs $0.94 Est., Sales $99.4M vs $101M ESt.",2015-05-06 16:17:00-04:00,LCI,neutral
753562.0,"Earnings Scheduled For May 6, 2015",2015-05-06 04:23:00-04:00,LCI,neutral
753563.0,"OvaScience, Fred's, Weight Watchers Lead Wednesday's After-Hours Movers",2015-03-25 21:36:00-04:00,LCI,neutral
753564.0,"Lannett Company Reports Q2 EPS $1.21 Vs Est $1.06, Revs $114.8M Vs Est $102.95M",2015-02-04 16:08:00-05:00,LCI,neutral
753565.0,"Lannett Reports Prelim. Q2 EPS $1.18-$1.21 vs $0.92 Est., Sales ~$115M vs $97.5M Est.",2015-01-26 07:56:00-05:00,LCI,neutral
753566.0,"8-K from Lannett Shows Affirmed Q1, FY15 Outlook Ahead of JPMorgan Healthcare Conference Wednesday",2015-01-14 08:59:00-05:00,LCI,neutral
753567.0,UPDATE: Lannett Receives FDA Approval,2014-12-18 13:21:00-05:00,LCI,positive
753568.0,Lannett Receives FDA Approval For Dorzolamide HCL With Timolol,2014-12-18 13:20:00-05:00,LCI,positive
753569.0,Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2014-12-18 04:31:00-05:00,LCI,negative
753570.0,Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin,2014-12-09 05:09:00-05:00,LCI,positive
753571.0,"8-K from Lannett Shows Co. Served Grand Jury Subpoena on Dec. 5th, Related to Continuing Federal Probe of Generics Industry",2014-12-08 17:30:00-05:00,LCI,positive
753572.0,Lannett Names Michael Bogda as President,2014-12-05 08:10:00-05:00,LCI,neutral
753573.0,"Lannett Reports Ernest Sabo, VP of Regulatory Affairs, Chief Compliance Officer to Retire",2014-11-17 16:56:00-05:00,LCI,neutral
753574.0,8 Attractive U.S. Healthcare Stocks With Low PEG Ratios,2014-11-06 13:49:00-05:00,LCI,positive
753575.0,Shares of Mylan Move Lower; May be in Response to Lannett Subpoena News,2014-11-06 11:28:00-05:00,LCI,neutral
753576.0,Shares of Lannett Fall on 10Q Filing Showing Company Received Subpoena from Connecticut AG Concerning Investigation of Pricing of Digoxin,2014-11-06 11:13:00-05:00,LCI,positive
753577.0,"Lannett Reports Q1 Adj. EPS $0.22, Sales $93.4M",2014-11-03 16:08:00-05:00,LCI,neutral
753578.0,Stocks Hitting 52-Week Highs,2014-11-03 10:07:00-05:00,LCI,neutral
753579.0,"Lannett Announces Positive FDA Inspection Results, Only One Minor 483 Observation",2014-11-03 07:54:00-05:00,LCI,positive
753580.0,Lannett Announces FDA Approval for Letrozole Tablets USP 2.5mg,2014-10-29 14:28:00-04:00,LCI,positive
753581.0,Lannett Co Inc Reports Prelim Q1 EPS $0.91-0.94 vs $0.77 Est; Sees Sales $93.0M vs $90.70M Est,2014-10-23 07:55:00-04:00,LCI,neutral
753582.0,Class Action Lawsuit Against Lannett Voluntarily Dismissed Without Prejudice,2014-09-30 15:38:00-04:00,LCI,positive
753583.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2014-09-26 04:28:00-04:00,LCI,negative
753584.0,Lannett Launches Oxycodone Hydrochloride Oral Solution ,2014-09-22 07:29:00-04:00,LCI,positive
753585.0,"Lannett Reports Will Voluntarily Conduct Internal Review Related to Inquiry from Connecticut AG Received in Jul. 2014, Received Subpoena, Cites Review of Pricing of Digoxin",2014-09-16 07:55:00-04:00,LCI,neutral
753586.0,Lannett Receives FDA Approval for Oxycodone Hydrochloride Oral 100mg per 5ML,2014-09-10 13:36:00-04:00,LCI,positive
753587.0,Lannett Spikes Higher,2014-09-10 13:35:00-04:00,LCI,neutral
753588.0,"Worst Performing Industries For September 4, 2014",2014-09-04 11:01:00-04:00,LCI,negative
753589.0,Kirby McInerney Announces that Class Action Has Been Filed on Behalf of Lannet Company Investors ,2014-09-02 16:02:00-04:00,LCI,neutral
753590.0,Lannett Press Releases Confirms Earlier EPS Report,2014-08-27 16:05:00-04:00,LCI,neutral
753591.0,"Shares of Lannett Co. Parabolic Over Last Few Mins: Spiked to High at $40.18, Now Trading Up ~$0.25 from Prior to Apparent Earnings Leak",2014-08-27 15:36:00-04:00,LCI,negative
753592.0,Lannett Co Inc Sees FY2015 Sales $350.0M-370.0M vs $349.60M Est,2014-08-27 15:28:00-04:00,LCI,neutral
753593.0,Lannett Co Inc Reports Q4 EPS of $0.64 Which May Not Compare $0.58 Est; Revenue of $80.60M Which May Not Compare $79.06M Est - Bloomberg,2014-08-27 15:27:00-04:00,LCI,neutral
753594.0,"Earnings Scheduled For August 27, 2014",2014-08-27 05:32:00-04:00,LCI,neutral
753595.0,Lannett To Acquire Two Generic Pharmaceutical Products,2014-08-20 11:31:00-04:00,LCI,neutral
753596.0,"Lannett Comments On JACC Study, Says Does Not Expect Digoxin Prescriptions To Be Significantly Impacted",2014-08-20 10:07:00-04:00,LCI,neutral
753597.0,"Lannett Sinks On Safety, Pricing Worries Over Generic Heart Drug",2014-08-19 14:50:00-04:00,LCI,neutral
753598.0,Craig-Hallum Downgrades Lannett Co Inc to Hold,2014-08-19 12:29:00-04:00,LCI,neutral
753599.0,Dow Posts Triple-Digit Point Gain; S&P 500 And NASDAQ Also Higher As Global Concerns Calm,2014-08-18 16:59:00-04:00,LCI,positive
753600.0,Lannett Co Inc Sees FY2014 EPS $1.94-1.98 vs $1.75 Est; Sees Sales $274.0M vs $264.0M Est,2014-08-18 07:28:00-04:00,LCI,neutral
753601.0,Lannett Co Inc Reports Prelim. Q4 EPS $0.60-0.64; Sees Sales $81.0M vs $71.20M Est,2014-08-18 07:28:00-04:00,LCI,neutral
753602.0,Dow Breaks Four-Day Losing Streak As Calm Restores Last Week's Jittery Market,2014-08-04 16:57:00-04:00,LCI,positive
753603.0,UPDATE: Lannett Reports FDA Approval For Oxycodone Hydrochloride 5 mg Capsule,2014-08-04 07:55:00-04:00,LCI,positive
753604.0,Lannett Reports FDA Approval for Oxycodone Hydrochloride 5 mg Capsules,2014-08-04 07:53:00-04:00,LCI,positive
753605.0,Lannett Announces Deal to Become Exclusive US Distributor of Generic Aceon,2014-07-18 07:57:00-04:00,LCI,positive
753606.0,Earnings Continue Driving Markets Higher,2014-07-16 17:23:00-04:00,LCI,neutral
753607.0,Why Lannett Shares Are Down More Than 16%,2014-07-16 11:52:00-04:00,LCI,positive
753608.0,"Lannett Announces Has Received Inquiry from Connecticut AG, Related to Pricing of Digoxin",2014-07-16 11:33:00-04:00,LCI,neutral
753609.0,"Lannett Has Won FDA Approval for Codeine Sulfate Tablets USP, 15 mg, 30 mg, 60 mg",2014-06-16 12:37:00-04:00,LCI,positive
753610.0,Lannett to Be Added to S&P Small Cap 600 Index,2014-06-02 08:02:00-04:00,LCI,neutral
753611.0,UPDATE: Lannett Will Replace Zale in SmallCap 600,2014-05-29 17:17:00-04:00,LCI,neutral
753612.0,Lannett Will Join S&P SmallCap 600,2014-05-29 17:16:00-04:00,LCI,positive
753613.0,Lannett Announces Agreement with Sunshine Lake To Distribute Zidovudine,2014-05-12 07:53:00-04:00,LCI,positive
753614.0,Lannett Co Inc Reports Q3 EPS of $0.63 vs $0.60 Est; Revenue of $80.0M vs $84.50M Est,2014-05-07 16:05:00-04:00,LCI,neutral
753615.0,"Earnings Scheduled For May 7, 2014",2014-05-07 05:15:00-04:00,LCI,neutral
753616.0,Lannett Receives FDA Approval for Diazepam Oral Solution,2014-04-15 07:54:00-04:00,LCI,positive
753617.0,Lannett Reports Received FDA Approval for Diazepam Oral Solution,2014-04-15 07:54:00-04:00,LCI,positive
753618.0,10 US Stocks With EPS Growth Of Over 100%,2014-04-14 15:48:00-04:00,LCI,positive
753619.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates,2014-03-17 04:42:00-04:00,LCI,positive
753620.0,CORRECTION: Lannett Co Inc Raises FY2014 Sales Guidance from $245.0M-255.0M to $275.0M-285.0M vs $248.64 Est,2014-02-06 17:01:00-05:00,LCI,neutral
753621.0,Lannett Co Inc Sees FY2014 Sales $275.0M-285.0M vs $248.64M Est,2014-02-06 16:35:00-05:00,LCI,neutral
753622.0,Lannett Co Inc Reports Q4 EPS of $0.46 vs $0.39 Est; Revenue of $67.30M vs $62.21M Est,2014-02-06 16:34:00-05:00,LCI,neutral
753623.0,The Five Best Performing Stocks of 2013 ,2013-12-26 07:54:00-05:00,LCI,positive
753624.0,Form 8-K from Lannett Shows Co. Purchased Two Philadelphia Properties for $9M,2013-12-20 16:12:00-05:00,LCI,neutral
753625.0,"CEO Bedrosian Buys 5,000 Shares of Lannett -Form 4",2013-12-13 11:14:00-05:00,LCI,positive
753626.0,"Lannett to Begin Trading on NYSE as of December 13, 2013",2013-12-02 07:57:00-05:00,LCI,neutral
753627.0,Lannett Co Inc Reports Q1 EPS of $0.22 vs $0.13 Est; Revenue of $45.80M vs $41.17M Est,2013-11-07 16:10:00-05:00,LCI,neutral
753628.0,Lannett Co Inc Sees Q1 EPS $0.20-0.22 vs $0.07 Est; Sees Sales $45.0M vs $37.89M Est,2013-10-31 07:55:00-04:00,LCI,neutral
753629.0,UPDATE: Oppenheimer Upgraded Lannett Company and Set PT,2013-10-25 15:43:00-04:00,LCI,neutral
753630.0,Oppenheimer Upgrades Lannett Co Inc to Outperform,2013-10-25 13:21:00-04:00,LCI,neutral
753631.0,"Bank of America Initiates Coverage on Lannett Co Inc at Buy, Announces $27.00 PT",2013-10-25 07:07:00-04:00,LCI,neutral
753632.0,UPDATE: Oppenheimer Downgrades Lannett Company as Outperformance Leads to Fair Valuation,2013-10-23 11:12:00-04:00,LCI,positive
753633.0,"Oppenheimer Downgrades Lannett Co Inc to Perform, Removes $20.00 PT",2013-10-23 07:30:00-04:00,LCI,neutral
753634.0,"Lannett Closes Offering of 5,869,566 Shares at $18/Share for Net Proceeds ~$71.5M",2013-10-09 14:11:00-04:00,LCI,positive
753635.0,"Market Wrap For Friday, October 4: Markets Finish The Week Flat",2013-10-04 16:24:00-04:00,LCI,neutral
753636.0,Mid-Day Market Update: Aaron's Shares Fall After Lowered Q3 Outlook; Facebook Surges,2013-10-04 12:26:00-04:00,LCI,positive
753637.0,Mid-Morning Market Update: Markets Rise; Comtech Posts Upbeat Results,2013-10-04 10:33:00-04:00,LCI,neutral
753638.0,Morning Market Losers ,2013-10-04 10:06:00-04:00,LCI,negative
753639.0,"Needham Downgrades Lannett Co Inc to Hold, Removes $15.00 PT",2013-10-04 09:57:00-04:00,LCI,neutral
753640.0,Benzinga's Top Pre-Market Losers,2013-10-04 08:12:00-04:00,LCI,negative
753641.0,Lannett Prices 5.87M Shares at $18/Share,2013-10-04 08:04:00-04:00,LCI,positive
753642.0,Benzinga's Volume Movers,2013-09-11 10:45:00-04:00,LCI,neutral
753643.0,Lannett Co Inc Sees FY2013 Sales $181.0M-186.0M,2013-09-10 16:05:00-04:00,LCI,neutral
753644.0,Lannett Co Inc Reports Q4 EPS of $0.12 vs $0.07 Est; Revenue of $40.20M vs $37.89M Est,2013-09-10 16:03:00-04:00,LCI,neutral
753645.0,"Earnings Scheduled For September 10, 2013",2013-09-10 05:47:00-04:00,LCI,neutral
753646.0,Lannett Extends Exclusive Distribution Agreement with Jerome Stevens Pharmaceuticals ,2013-08-19 16:53:00-04:00,LCI,positive
753647.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-08-13 05:55:00-04:00,LCI,negative
753648.0,"Needham Initiates Coverage on Lannett Co Inc at Buy, Announces $15.00 PT",2013-05-23 08:18:00-04:00,LCI,neutral
753649.0,Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio ,2013-05-17 04:35:00-04:00,LCI,negative
753650.0,Lannett Co Inc Reports Q3 EPS of $0.14 vs $0.03 Est; Revenue of $39.0M vs $35.14M Est; Raises FY13 Sales Guidance from $140-142M to $147-149M vs $144.8M Est.,2013-05-08 16:41:00-04:00,LCI,neutral
753651.0,"Craig-Hallum Initiates Coverage on Lannett Co Inc at Buy, Announces $12.00 PT",2013-03-05 09:20:00-05:00,LCI,neutral
753652.0,Lannett Reports Q2 Prelim. EPS $0.08-0.10 on Sales ~$36M,2013-01-31 16:08:00-05:00,LCI,neutral
753653.0,"UPDATE: Canaccord Genuity Initiates Coverage on Lannett Company with Buy Rating, $7 PT",2012-11-09 11:29:00-05:00,LCI,neutral
753654.0,"Canaccord Initiates Coverage on Lannett at Buy, Announces PT of $7",2012-11-09 05:50:00-05:00,LCI,neutral
753655.0,Lannett Reports Q1 EPS $0.10 vs $0.05 Est; Revenues $35.3M vs $33.76M Est,2012-11-08 16:03:00-05:00,LCI,neutral
753656.0,"In a Form 8-K, Lannett Filed to Sell $121.25M in Stock, Debt and Warrants",2012-11-02 12:24:00-04:00,LCI,negative
753657.0,"Lannett Gets FDA Approval for Butalbital, Acetaminophen",2012-09-14 08:04:00-04:00,LCI,positive
753658.0,Lannett Reports Q4 EPS $0.05 vs $0.03 Est; Revenues $35.7M vs $33.08M Est,2012-09-06 16:07:00-04:00,LCI,neutral
753659.0,"Earnings Scheduled For September 6, 2012",2012-09-06 04:22:00-04:00,LCI,neutral
753660.0,Lannett Company Names Jeffrey Farber as Chairman   ,2012-07-16 16:05:00-04:00,LCI,neutral
753661.0,Lannett Reports Q3 EPS $0.06 vs $0.04 Est; Net Sales $30.7M vs $31.52M Est,2012-05-08 16:09:00-04:00,LCI,neutral
753662.0,"Lannett Receives FDA Approval for ANDA Supplement for Phentermine HCL Capsules, 15 mg",2012-01-31 08:05:00-05:00,LCI,positive
753663.0,"Lannett Receives FDA Approval for Hydrochlorothiazide Capsules, 12.5 mg   ",2012-01-30 08:15:00-05:00,LCI,positive
753664.0,Lannett Receives Letter from NYSE Amex Regarding Timely Notice of Record Date for 2012 Annual Shareholders Meeting   ,2012-01-06 16:31:00-05:00,LCI,neutral
753665.0,Lannett Reaches Special Protocol Assessment Agreement with FDA for Cocaine HCl Phase III Trial,2012-01-04 11:40:00-05:00,LCI,positive
753666.0,Lannett Receives FDA Approval for Triamterene with Hydrochlorothiazide 37.5/25mg Capsules,2011-12-12 14:44:00-05:00,LCI,positive
753667.0,"Lannett Receives FDA Approval for Diethylpropion HCl Extended Release Tablets, 75 mg   ",2011-10-24 13:36:00-04:00,LCI,positive
753668.0,"Mylan Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-21 16:07:00-04:00,LCI,neutral
753669.0,Lannett Launches Three Recently Approved Products   ,2011-10-14 08:01:00-04:00,LCI,positive
753670.0,Lannett Receives FDA Approval for Loxapine Capsules,2011-09-27 08:02:00-04:00,LCI,positive
753671.0,"Lannett Company CEO Purchases 20,467 Shares of Company's Stock   ",2011-09-12 16:18:00-04:00,LCI,positive
753672.0,Earnings Scheduled For September 7,2011-09-07 04:02:00-04:00,LCI,neutral
753673.0,Lannett Appoints Jeffrey Farber as Vice Chairman   ,2011-08-16 08:10:00-04:00,LCI,neutral
753674.0,Lannett Launches Morphine Sulfate Oral Solution   ,2011-08-11 08:12:00-04:00,LCI,positive
753675.0,Lannett Names Martin Galvan as CFO,2011-08-08 10:16:00-04:00,LCI,neutral
753676.0,Lannett Announces Chief Financial Officer Resignation   ,2011-08-02 14:34:00-04:00,LCI,negative
753677.0,"Lannett Receives FDA Approval for Phentermine HCl Capsules, 37.5 mg   ",2011-07-20 15:33:00-04:00,LCI,positive
753678.0,"Lannett Receives FDA Approval for Diethylproprion HCl Tablets, 25 mg   ",2011-07-18 13:28:00-04:00,LCI,positive
753679.0,Lannett Announces Appointment of CIO   ,2011-07-05 15:42:00-04:00,LCI,neutral
753680.0,Lannett Receives FDA Approval for Morphine Sulfate Oral Solution NDA ,2011-06-24 09:35:00-04:00,LCI,positive
753681.0,Lannett Confirms that a Press Release About its Morphine Sulfate Oral Solution FDA Response will be Released Today,2011-06-24 09:13:00-04:00,LCI,positive
753682.0,Hearing Lannett to Announce FDA Response to Morphine Sulfate Oral Solution Later Today -Rumor,2011-06-24 08:37:00-04:00,LCI,positive
753683.0,"FDA PDUFA Dates Scheduled for Tomorrow: LCI, DRRX, and PITE",2011-06-22 09:30:00-04:00,LCI,neutral
753684.0,Lannett Announces Revised FDA PDUFA Date for Morphine Sulfate Oral Solution NDA   ,2011-06-06 13:15:00-04:00,LCI,positive
753685.0,Lannett Announces Change to Board of Directors,2011-06-01 08:02:00-04:00,LCI,neutral
753686.0,"Lannett CEO Purchases 5,000 Shares of Company in Open Market ",2011-05-18 13:21:00-04:00,LCI,positive
753687.0,Oppenheimer Initiates Coverage Of LCI With Outperform,2011-03-30 08:53:00-04:00,LCI,neutral
753688.0,"Oppenheimer Initiates Coverage Of Lannett At Outperform, $7 PT (LCI)",2011-03-30 07:33:00-04:00,LCI,neutral
753689.0,Lannett Announces Positive Results of Facilities Inspection in Philadelphia,2011-03-22 14:55:00-04:00,LCI,positive
753690.0,Lannett Company Expecting Facility Approval Soon (LCI),2011-03-15 13:16:00-04:00,LCI,positive
753691.0,Lannett Fights Back After Recent Article Says It Failed A High Number Of FDA Inspections,2011-03-04 08:19:00-05:00,LCI,negative
753692.0,Lannett Reports Q2 EPS of $0.09 vs. $0.02,2011-02-10 11:01:00-05:00,LCI,neutral
753693.0,Lannett Nears FDA Approval; Awaits Facility Clearance (LCI),2011-02-01 08:14:00-05:00,LCI,positive
753694.0,Bearish MACD for LCI - Tale of the Tape,2011-01-24 11:31:00-05:00,LCI,neutral
753695.0,Bearish MACD for LCI - Tale of the Tape,2011-01-24 09:50:00-05:00,LCI,neutral
753696.0,Hearing Lannett Company Vice President Retired (LCI),2011-01-03 15:36:00-05:00,LCI,neutral
753697.0,Lannett Company Expecting FDA Decision (LCI),2010-12-27 15:19:00-05:00,LCI,neutral
753698.0,Lannett Prices its Stock Offering at $5.00 per Share,2010-12-14 09:31:00-05:00,LCI,positive
753699.0,Lannett Announces Public Offering ,2010-12-13 16:02:00-05:00,LCI,neutral
753700.0,Lannett Company Plunging ,2010-12-13 11:38:00-05:00,LCI,neutral
753701.0,Lannett Reports 2011 First Quarter EPS of $(0.02),2010-11-11 12:43:00-05:00,LCI,neutral
753702.0,Lannett Co. Beats on Top and Bottom Lines (LCI),2010-09-13 16:21:00-04:00,LCI,positive
753703.0,Lannett Reports Fiscal 2010 Fourth Quarter Results,2010-09-13 14:01:00-04:00,LCI,neutral
753704.0,"Earnings Scheduled For September 13 (FUL, TRR, MTRX, PCYC, NTSC, MSB, LCI, LRN, GCOM,  FEIM, FARM, CHP)",2010-09-13 07:05:00-04:00,LCI,neutral
